chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Neoplasm malignant, Oropharyngeal pain, Platelet count decreased, Rash macular, Skin warm
Clinical narrative: The very next day extreme exhaustion, sever headache, sore throat, stomach pain, extreme dizziness.  Pain in breast and lymph node in arm pit. This all went on for a month. I went in to get it looked at ( I could barely function at home without needing to lay down and d Nap for a month) had blood work drawn, platelets were 630. Got the second shot, got Covid arm (large, red, hot spot on arm) went back many more times. My period went on for almost 2 weeks, breast?s were over sensitive. I kept going to get checked out. Migraines were so bad and I was loosing vision, and blurred vision. Eventually I was referred to a hematologist and diagnosed with ET. A rare chronic blood cancer that normally affects older people. ( essential thrombosis) I have had 2 mini strokes since then. I felt totally normal before the vaccine. I have never felt right since the moment I got the vaccine. It triggered something. I just knew it. Even when some doctors turned me away and said it was nothing, that I was fine. I kept looking because I know my body very well. Something was off. Now I have cancer.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack, Vaccination complication, Vision blurred
Clinical narrative: The very next day extreme exhaustion, sever headache, sore throat, stomach pain, extreme dizziness.  Pain in breast and lymph node in arm pit. This all went on for a month. I went in to get it looked at ( I could barely function at home without needing to lay down and d Nap for a month) had blood work drawn, platelets were 630. Got the second shot, got Covid arm (large, red, hot spot on arm) went back many more times. My period went on for almost 2 weeks, breast?s were over sensitive. I kept going to get checked out. Migraines were so bad and I was loosing vision, and blurred vision. Eventually I was referred to a hematologist and diagnosed with ET. A rare chronic blood cancer that normally affects older people. ( essential thrombosis) I have had 2 mini strokes since then. I felt totally normal before the vaccine. I have never felt right since the moment I got the vaccine. It triggered something. I just knew it. Even when some doctors turned me away and said it was nothing, that I was fine. I kept looking because I know my body very well. Something was off. Now I have cancer.
Age: 0.33
Sex: F
Vaccine: RV5
Symptoms: Haematochezia
Clinical narrative: Patient had blood in stool for 3 days following vaccine. Onset of blood in stool was 2.5 hours following vaccine and was not associated with any fussiness or any other notable symptoms.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Cardiac stress test, Chest X-ray, Chest discomfort
Clinical narrative: I felt light headed, weak, shortness of breath and chest pain. Discomfort in my chest area.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: I felt light headed, weak, shortness of breath and chest pain. Discomfort in my chest area.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: GIVEN 2 DAYS PAST EXPIRATION. NO ADVERSE REACTION.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, COVID-19, Chills, Cough, Diarrhoea
Clinical narrative: Complaint of cough, chills, elevated temperature (102), sore/scratchy throat, headache, runny nose/congestion, myalgia, malaise, diarrhea, and nausea.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Malaise, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: Complaint of cough, chills, elevated temperature (102), sore/scratchy throat, headache, runny nose/congestion, myalgia, malaise, diarrhea, and nausea.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: Complaint of cough, chills, elevated temperature (102), sore/scratchy throat, headache, runny nose/congestion, myalgia, malaise, diarrhea, and nausea.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hypotonia, Induration, Inflammatory marker test, Mammogram
Clinical narrative: Swelling. Pain. Heat, itchy, hard ,goes limp, shakes
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Swelling, Tremor, Ultrasound breast
Clinical narrative: Swelling. Pain. Heat, itchy, hard ,goes limp, shakes
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, X-ray
Clinical narrative: Swelling. Pain. Heat, itchy, hard ,goes limp, shakes
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Syncope
Clinical narrative: Injection given at 3:56.  Pt seated in chair at 4:05,  Pt complained of dizziness, became diaphoretic, fainted. Regained consciousness. Alert and oriented x3. At 4:05  -Vital Signs- 113/57-56-20 Pulse Ox  100% At 4:25- 130/83 - 59 - 20 patient eating and drinking without difficulty. At 4:50- 131/91-64-20 Temp 97.1
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Erythema, Headache
Clinical narrative: Red hard bump extending to about as far across as a baseball...still in existence at 8 days. Extremely painful muscles and joints, body-wide, level 8 on a 1-10 pain scale.  Headache with dizziness and chills from October 9-13.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Swelling
Clinical narrative: Red hard bump extending to about as far across as a baseball...still in existence at 8 days. Extremely painful muscles and joints, body-wide, level 8 on a 1-10 pain scale.  Headache with dizziness and chills from October 9-13.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Vaccine was given one day to early after the 4 day grace period. No treatment given
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: ADMINISTERED 2 DAYS PAST EXPIRATION; NO ADVERSE REACTION.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Severe headache that could not be alleviated with Tylenol or Aleve for 24 hours Extreme muscle soreness, especially in left arm for 24 hours. Low-grade fever for 48 hours
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received a Janssen shot after already receiving a Janssen shot about 6 months earlier.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: ADMINISTERED 2 DAYS PAST EXPIRATION; NO ADVERSE REACTION.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles and prolonged side effects of shingles
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Musculoskeletal stiffness, Oedema peripheral
Clinical narrative: Stiffness and swelling in lymph nodes around the neck. Painful swelling  in the armpit . I was told to manage with ibuprofen and allergy meds.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: 101.0 F fever, body ache, headache and mild pain in the right arm
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Chills, Paraesthesia, Pyrexia
Clinical narrative: After the initial fever, chills and vomiting for two day after shot, I now have weird tingling under my skin across my entire back. Almost like their is something crawling around under my skin. Sometimes that feeling extends to shoulders and hips. I feel weak most of the day.  My blood pressure is more elevated than normal.  It has been 14 days since the shot.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: After the initial fever, chills and vomiting for two day after shot, I now have weird tingling under my skin across my entire back. Almost like their is something crawling around under my skin. Sometimes that feeling extends to shoulders and hips. I feel weak most of the day.  My blood pressure is more elevated than normal.  It has been 14 days since the shot.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Angiogram pulmonary abnormal, Anion gap, Antibody test negative, Anxiety
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Aspartate aminotransferase increased, Basophil percentage decreased, Blood albumin normal, Blood alkaline phosphatase normal, Blood bicarbonate increased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood bilirubin normal, Blood chloride normal, Blood creatinine normal, Blood culture negative, Blood gases
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Blood ketone body, Blood lactate dehydrogenase increased, Blood lactic acid, Blood osmolarity decreased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH increased, Blood potassium normal, Blood sodium normal, Blood urea increased, Brain natriuretic peptide increased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, COVID-19 pneumonia, Carbon dioxide increased, Chest X-ray abnormal
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Differential white blood cell count, Dyspnoea, Eosinophil percentage decreased, Fibrin D dimer increased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Glomerular filtration rate normal, Haematocrit normal, Haemoglobin normal, Hepatitis B core antibody negative, Hepatitis B surface antibody negative
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis C antibody negative, Immature granulocyte count, Immunology test, Inflammatory marker test, Intensive care
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio normal, Laboratory test normal, Lipase normal, Lung consolidation, Lymphocyte percentage decreased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mitogen stimulation test, Monocyte percentage, Mycobacterium tuberculosis complex test negative, Neutrophil count increased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil percentage increased, Oxygen saturation decreased, PCO2 normal, PO2 decreased, Platelet count normal
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet morphology normal, Pneumonia, Polychromasia, Protein total decreased, Prothrombin time prolonged
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell count normal, Red blood cell microcytes present, Red blood cell nucleated morphology, Red cell distribution width normal, Respiratory failure
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Superinfection, Troponin I normal, White blood cell count increased
Clinical narrative: 45 Y male with h/o IDDM, severe obesity (BMI 40.35), OSA, CT Chest findings suggestive of RAD, recent hospitalizations for hypoxic respiratory failure (8/22-8/26, 9/14-9/17 s/p prednisone taper) on home O2 2L, who presented with +COVID 9/29 with worsening shortness of breath and transferred to the ICU for rapidly escalating oxygen requirements.   Hx of recent admissions for acute on chronic hypoxic respiratory failure (8/2-8/26, 9/14-9/17) on 2L home O2, possible small airway disease. OSA with CPAP but not compliant at home, likely contributory factor of OHS and OSA. Hx of CAP 8/22 s/p cftx/azithro. Recent CTA 8/22 w/ possible small airway disease. Recently seen as an outpatient (9/21). CTA performed on last admission (08/22) with questionable subtle groundglass opacities in the upper lobes left greater than right which may be infectious or inflammatory, air trapping in upper lobes on expiratory views, diff dx bronchiolitis obliterans or other small airways disease. Outpt infectious workup overall negative. Thought to be possibly environmental, as patient works at a car company on the manufacturing line and is exposed to a lot of smoke & welding fumes. S/p recent prednisone taper  (9/14-9/25). Symptom onset on 9/28, SARS-CoV2 PCR positive on 9/29. spO2 95% on 40L 80% at time of presentation and required HFNC 40L 100% FiO2 to maintain SpO2 >95%. CXR 10/3 with diffuse multifocal consolidation and opacity suspicious for pneumonia.  Received remdesivir 200 mg Ivx1 and dexamethasone 6mg IV x2 in ED. CTA negative for PE but with GGO/ diffuse consolidations. ABG on 10/4 7.45/37/55. Continues to have borderline sats. Repeat ABG on 10/5 improved at 7.43/38/91. CXR unchanged. Currently with cough, SOB that may be exacerbated by anxiety and worsening COVID vs superimposed infection, although ABG improved and inflammatory markers down-trending. Procalcitonin elevated at 0.27, not elevated prior. D-dimer also elevated, suspect superimposed infection +/- PE as patient's oxygen needs have remained despite inflammatory markers down-trending. Pt left AMA 10/9.  Reason for Hospital Admission (Admitting Diagnosis):  Covid Pna  Pt was seen again in ED on 10/14 High Risk patient with Severe symptoms.  Sx are Stable but not improving  - Addressed patient's questions about COVID-19
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chest pain, Dyspnoea, Electrocardiogram, Pericarditis
Clinical narrative: I went to the medical facility here after experiencing sharp pain in my chest and short of breath and after the doctor ran an EKG they believe I have pericarditis that has been lingering for about 2-3 weeks.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: I went to the medical facility here after experiencing sharp pain in my chest and short of breath and after the doctor ran an EKG they believe I have pericarditis that has been lingering for about 2-3 weeks.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear swelling, Herpes zoster, Nasopharyngitis, Pain in jaw
Clinical narrative: I was having cold symptoms and was having small bubbles temple on my face on the right and it spread to the entire top side of face. Lots of swelling on the ear and jaw and pain. I had two at home test that was positive but clinic test was negative. Clinic for covid testing on 12Sep2021 & 1Oct2021. Urgent care on 29Sep2021 diagnosed as shingles and went to eye doctor the next am. Shingles was on eyelid.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, SARS-CoV-2 test positive, Swelling face
Clinical narrative: I was having cold symptoms and was having small bubbles temple on my face on the right and it spread to the entire top side of face. Lots of swelling on the ear and jaw and pain. I had two at home test that was positive but clinic test was negative. Clinic for covid testing on 12Sep2021 & 1Oct2021. Urgent care on 29Sep2021 diagnosed as shingles and went to eye doctor the next am. Shingles was on eyelid.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Malaise, Myalgia
Clinical narrative: Complaint of sore/scratchy throat, runny nose/congestion, lose of taste and smell, myalgia and malaise
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: Complaint of sore/scratchy throat, runny nose/congestion, lose of taste and smell, myalgia and malaise
Age: 49.0
Sex: F
Vaccine: FLU4
Symptoms: Burning sensation, Full blood count, Pruritus
Clinical narrative: 3 days after vaccination, itchy left arm - back and inside of arm, armpit, some chest and upper back. Itchiness/burning sedation comes and goes. Lasting for one week so far.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: ADMINISTERED 2 DAYS PAST EXPIRATION; NO ADVERSE REACTION
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac disorder, Dyspnoea
Clinical narrative: Pt onset 9/5 and symptoms progressed . On 9/12 Pt was having difficulty breathing and having heart issues so 911 was called and EMS Transported PT from home address to  Hospital and she has been in the hospital since. Pt has AFIB and has history of valve issues. Pt is fully vx and received Dose 2 on 4/26.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Headache, Nausea, Pruritus
Clinical narrative: Symptoms: "COVID Arm" - rash, redness, hives, itching, burning, hot to the touch - down entire left arm, up left side of neck, across chest and back, constant headache, nausea. Duration: 3 weeks